ClinicalTrials.Veeva

Menu

Study on the Pathogenesis of Retinal Vascular Diseases Based on Body Fluid Metabolomics

Z

Zhongnan Hospital

Status

Invitation-only

Conditions

Metabolomics; Retinopathy; Etiology

Treatments

Other: etiology

Study type

Observational

Funder types

Other

Identifiers

NCT06408571
20240202

Details and patient eligibility

About

Through the analysis of metabolites in body fluids (intraocular fluid, plasma) of patients with retinal vascular diseases (retinal vein occlusion, diabetic retinopathy), the possible pathogenesis of retinal vein occlusion was explored.

Full description

  1. Clinical data of patients with RVO and DR Were retrospectively studied to analyze their pathogenesis. 2. Metabolomic studies were conducted on body fluids (intraocular fluid and peripheral blood) of patients with RVO and DR And control group to find out the differences and find new targets for the prevention and treatment of RVO and DR.

Enrollment

3,900 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥18 years old
  • Confirmed diagnosis of retinal vein obstruction and diabetic retinopathy through ophthalmic specialist examination

Exclusion criteria

  • Severe systemic diseases
  • Pregnant and lactating patients

Trial design

3,900 participants in 2 patient groups

Experimental group
Description:
Patients with retinal vein obstruction and diabetic retinopathy
Treatment:
Other: etiology
Control group
Description:
Cataract surgery and vitrectomy patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems